Exploring the mechanism of Heidihuang Pill in the treatment of osteoporosis based on network pharmacology, molecular docking, and experimental validation
Abstract
BACKGROUND: Currently, anti-osteoporosis (OP) treatment imposes a certain economic burden on patients and society; therefore, studies have focused on exploring anti-OP therapies. As a classic prescription in traditional Chinese medicine (TCM), the Heidihuang Pill (HP) was clinically shown to alleviate OP. However, the mechanism behind its effect remains unclear. We aimed to determine this mechanism using methods such as network pharmacology and experimental verification.
METHODS: Network pharmacology was used to identify the active ingredients, targets, and mechanisms of action of HP in treating OP. Molecular docking technology was then used to verify the interactions between the active ingredients and target proteins. Finally, an OP rat model was established through in vivo experiments to validate the results obtained from network pharmacology.
RESULTS: Overall, 178 targets were retrieved, which are key targets of HP for treating OP. Protein-Protein Interaction network analysis showed that RAC-alpha serine/threonine-protein kinase (Akt1) (degree =132) was the most reliable target of HP for treating OP. Gene Ontology functional analysis revealed that the regulation of HP on OP mainly occurs as follows: it mainly manifests as a response to hormones in biological processes; it mainly acts on membrane rafts in cellular components; and it mainly involves the binding of transcription factors in molecular functions. Kyoto Encyclopedia of Genes and Genomes pathway enrichment…
Read the paper
Related studies
- Development of a crushable foam model for human trabecular bone
- Data-driven motion compensation in HR-pQCT.
- Modeling of structure, quality, and function in the orthodontic patient
- Effect of fabric on the accuracy of computed tomography-based finite element analyses of the vertebra
- Use of interventions involving virtual reality tasks during the climacteric: a systematic review
- Model selection in competing risks regression
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.